• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dopamine agonist-induced impulse control disorders in a patient with prolactinoma.

作者信息

Almanzar Santiago, Zapata-Vega Maria I, Raya Juan A

机构信息

Department of Psychiatry, Mount Sinai School of Medicine at Elmhurst Hospital Center, Elmhurst, NY 11373, USA.

出版信息

Psychosomatics. 2013 Jul-Aug;54(4):387-91. doi: 10.1016/j.psym.2012.10.002. Epub 2012 Dec 20.

DOI:10.1016/j.psym.2012.10.002
PMID:23261076
Abstract
摘要

相似文献

1
Dopamine agonist-induced impulse control disorders in a patient with prolactinoma.一名泌乳素瘤患者出现多巴胺激动剂诱发的冲动控制障碍。
Psychosomatics. 2013 Jul-Aug;54(4):387-91. doi: 10.1016/j.psym.2012.10.002. Epub 2012 Dec 20.
2
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.多巴胺激动剂治疗的性腺功能减退伴泌乳素瘤男性中的多巴-测试毒性：破坏性的性欲亢进。
Endocrine. 2017 Feb;55(2):618-624. doi: 10.1007/s12020-016-1088-1. Epub 2016 Sep 6.
3
Treating prolactinomas with dopamine agonists: always worth the gamble?使用多巴胺激动剂治疗泌乳素瘤：总是值得一试吗？
Endocrine. 2016 Feb;51(2):205-10. doi: 10.1007/s12020-015-0727-2. Epub 2015 Sep 4.
4
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.长期服用溴隐亭和卡麦角林的泌乳素瘤患者出现亚临床心脏瓣膜纤维化的患病率增加。
Eur J Endocrinol. 2012 Jul;167(1):17-25. doi: 10.1530/EJE-12-0121. Epub 2012 Apr 16.
5
A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With Prolactinoma.泌乳素瘤患者多巴胺激动剂诱发的冲动控制障碍的遗传学评估
J Clin Endocrinol Metab. 2023 May 17;108(6):e275-e282. doi: 10.1210/clinem/dgac718.
6
Pituitary apoplexy associated with cabergoline therapy.与卡麦角林治疗相关的垂体卒中。
J Clin Neurosci. 2013 Dec;20(12):1637-43. doi: 10.1016/j.jocn.2013.02.027. Epub 2013 Oct 7.
7
[Prolactinoma and pregnancy].[泌乳素瘤与妊娠]
Akush Ginekol (Sofiia). 2004;43 Suppl 2:16-22.
8
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.多巴胺激动剂卡麦角林对不耐受或抵抗溴隐亭的泌乳素瘤患者的影响。
Eur J Endocrinol. 1996 Apr;134(4):454-6. doi: 10.1530/eje.0.1340454.
9
Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.使用卡麦角林治疗囊性大泌乳素瘤期间发生垂体卒中。
Pituitary. 2008;11(3):287-92. doi: 10.1007/s11102-007-0046-6.
10
Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.卡麦角林治疗侵袭性大泌乳素瘤期间出现气颅。
Acta Clin Belg. 2009 Sep-Oct;64(5):457. doi: 10.1179/acb.2009.078.

引用本文的文献

1
Impulse Control Disorders in Southern Iraqi Patients Medicated With Cabergoline for Prolactinoma.伊拉克南部使用卡麦角林治疗泌乳素瘤患者的冲动控制障碍
Cureus. 2024 Apr 18;16(4):e58516. doi: 10.7759/cureus.58516. eCollection 2024 Apr.
2
Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study.多巴胺激动剂治疗的垂体腺瘤患者的冲动控制障碍：一项横断面多中心研究。
Pituitary. 2024 Apr;27(2):197-203. doi: 10.1007/s11102-024-01383-2. Epub 2024 Feb 12.
3
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.
高泌乳素血症患者多巴胺激动剂治疗后出现冲动控制障碍。
Rev Endocr Metab Disord. 2022 Oct;23(5):1089-1099. doi: 10.1007/s11154-022-09753-6. Epub 2022 Sep 20.
4
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study.在接受多巴胺激动剂治疗的内分泌疾病患者中，冲动控制障碍症状的患病率增加：一项横断面研究。
J Endocrinol Invest. 2021 Aug;44(8):1699-1706. doi: 10.1007/s40618-020-01478-0. Epub 2020 Dec 12.
5
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.高催乳素血症和催乳素瘤管理中的争议问题——巴西内分泌与代谢学会神经内分泌学部门概述
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):236-263. doi: 10.20945/2359-3997000000032.
6
Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.多巴胺能疗法的神经精神和代谢方面：内分泌学家和精神科医生的观点。
Endocr Connect. 2018 Feb;7(2):R88-R94. doi: 10.1530/EC-18-0030. Epub 2018 Jan 29.
7
Dopamine Agonists and Impulse Control Disorders: A Complex Association.多巴胺激动剂与冲动控制障碍：复杂的关联。
Drug Saf. 2018 Jan;41(1):19-75. doi: 10.1007/s40264-017-0590-6.
8
Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study.多巴胺激动剂治疗的泌乳素瘤和无功能垂体腺瘤患者的冲动控制障碍：一项病例对照研究。
Clin Endocrinol (Oxf). 2014 Jun;80(6):863-8. doi: 10.1111/cen.12375. Epub 2013 Dec 16.